Regardless of who Teva's partner is, whether that be Protalix, Taro, Ranbaxy, etc., would you say that upon learning of Teva's partner that you (a) became less confident of Teva ultimately obtaining approval for its generic Lovenox; (b) became more confident that Teva will ultimately receive approval; or (c) remained relatively unchanged in your opinion?
Market Data 
Markets 
AI
